NCT07140614 - A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

February 25, 2028

Study Completion Date

February 26, 2028

Conditions

Charcot-Marie-Tooth Disease, Type 1A

Interventions

DRUG

EDK060, dose A

EDK060, dose A, Single dose, IV infusion

DRUG

EDK060, dose B

EDK060, dose B, Single dose, IV infusion

DRUG

EDK060, dose C

EDK060, dose C, Single dose, IV infusion

DRUG

EDK060, dose D

EDK060, dose D, Single dose, IV infusion

OTHER

Placebo

Trial Locations (2)

RECRUITING

Novartis Investigative Site, Montreal

RECRUITING

Novartis Investigative Site, Sherbrooke